Continuous nonradioactive method for screening trypanosomal transsialidase activity and its inhibitors

Glycobiology

Volumn 20, Issue 8, 2010, Pages 982-990

  Sartor, Paula A ^a   Agusti, Rosalía ^a   Leguizamón, Maria S ^a   Campetella, Oscar ^b   de Lederkremer, Rosa M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

Author keywords

Galactose oxidase; Inhibitors; Trans sialidase; Trypanosoma cruzi

Indexed keywords

FETUIN; SIALIC ACID; SIALIDASE; SIALIDASE INHIBITOR;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CARBOHYDRATE ANALYSIS; ENZYME INHIBITION; ENZYME SUBSTRATE; GLYCOSYLATION; NONHUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY; TRYPANOSOMA CRUZI;

ALPHA-FETOPROTEINS; ENZYME INHIBITORS; GALACTOSE; GLYCOPROTEINS; NEURAMINIDASE; OLIGOSACCHARIDES; SIALIC ACIDS; STAINING AND LABELING; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOSOMA CRUZI;

MAMMALIA; TETRA; TRYPANOSOMA CRUZI;

EID: 77954483622     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwq056     Document Type: Article

References (41)

1. Agusti R, Couto AS, Campetella OE, Frasch ACC, de Lederkremer RM. 1997. The trans-sialidase of Trypanosoma cruzi is anchored by two different lipids. Glycobiology. 7:731-735.
2. Agusti R, Couto AS, Campetella O, Frasch AC, de Lederkremer RM. 1998. Structure of the glycosylphosphatidylinositol-anchor of the trans-sialidase from Trypanosoma cruzi metacyclic trypomastigote forms. Mol Biochem Parasitol. 97:123-131.
3. Agusti R, Paris G, Ratier L, Frasch AC, de Lederkremer RM. 2004. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo. Glycobiology. 14:659-670.
4. Agusti R, Giorgi ME, Mendoza VM, Gallo-Rodriguez C, de Lederkremer RM. 2007. Comparative rates of sialylation by recombinant trans-sialidase and inhibitor properties of synthetic oligosaccharides from Trypanosoma cruzi mucins-containing galactofuranose and galactopyranose. Bioorg Med Chem. 15:2611-2616.
5. Alvarez P, Buscaglia CA, Campetella O. 2004. Improving protein pharmacokinetics by genetic fusion to simple amino acid sequences. J Biol Chem. 279:3375-3381.
6. Blejer JL, Sartor PA, Bottasso O, Salamone HJ, Leguizamón MS. 2008. Transsialidase inhibition assay for the detection of Trypanosoma cruzi infection in blood donor samples from Argentina. Vox Sang. 95:189-196.
7. Buscaglia CA, Alfonso J, Campetella O, Frasch AC. 1999. Tandem amino acid repeats from Trypanosoma cruzi shed antigens increase the half-life of proteins in blood. Blood. 93:2025-2032.
8. Buschiazzo A, Frasch AC, Campetella O. 1996. Medium scale production and purication to homogeneity of a recombinant trans-sialidase from Trypanosoma cruzi. Cell Mol Biol (Noisy-le-grand). 42:703-710.
9. Buschiazzo A, Amaya MF, Cremona ML, Frasch AC, Alzari PM. 2002. The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis. Mol Cell. 10:757-768.
10. Ferrero-Garcia MA, Trombetta SE, Sanchez DO, Reglero A, Frasch AC, Parodi AJ. 1993. The action of Trypanosoma cruzi trans-sialidase on glycolipids and glycoproteins. Eur J Biochem. 213:765-771.
11. Frasch AC. 2000. Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi. Parasitol Today. 16:282-286.
12. Kinoshita M, Inagake K, Kawabata A, Kuroda R, Oda Y, Kakehi K. 2000. Fluorometric determination of mucin-type glycoproteins by the galactose oxidase-peroxidase method. Anal Biochem. 284:87-92.
13. Kuhn R, Baer HH, Seeliger A. 1958. Zur Methylierung Von N-Acetylglucosamin-Derivaten. Lieb Ann. 611:236-241.
14. de Lederkremer RM, Agusti R. 2009. Glycobiology of Trypanosoma cruzi. Adv Carbohydr Chem Biochem. 62:311-366.
15. Lee SG, Kim BG. 2000. Development of spectrophotometric method for monitoring trans-sialidase reaction and its application. Biotechnol Lett. 22:819-823.
16. Leguizamón MS, Campetella OE, González Cappa SM, Frasch AC. 1994. Mice infected with Trypanosoma cruzi produce antibodies against the enzymatic domain of trans-sialidase that inhibit its activity. Infect Immun. 62:3441-3446.
17. Leguizamón MS, Campetella O, Russomando G, Almiron M, Guillen I, González Cappa SM, Frasch AC. 1994. Antibodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections. J Infect Dis. 170:1570-1574.
18. Leguizamón MS, Russomando G, Luquetti A, Rassi A, Almiron M, GonzálezCappa SM, Frasch AC, Campetella O. 1997. Long-lasting antibodies de-tected by a trans-sialidase inhibition assay of sera from parasite-free, serologically cured chagasic patients. J Infect Dis. 175:1272-1275.
19. Leguizamón MS, Mocetti E, Garcia Rivello H, Argibay P, Campetella O. 1999. Trans-sialidase from Trypanosoma cruzi induces apoptosis in cells from the immune system in vivo. J Infect Dis. 180:1398-1402.
20. Lineweaver G, Burk D. 1934. The determination of enzyme dissociation constants. J Am Chem Soc. 56:658-666.
21. Mohanty JG, Jaffe JS, Schulman ES, Raible DG. 1997. A highly sensitive uorescent micro-assay of H2O2 release from activated human leukocytes using a dihydroxyphenoxazine derivative. J Immunol Methods. 202:133-141.
22. Mucci J, Hidalgo A, Mocetti E, Argibay PF, Leguizamón MS, Campetella O. 2002. Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex. Proc Natl Acad Sci USA. 99:3896-3901.
23. Mucci J, Mocetti E, Leguizamón MS, Campetella O. 2005. A sexual dimorphism in intrathymic sialylation survey is revealed by the trans-sialidase from Trypanosoma cruzi. J Immunol. 174:4545-4550.
24. Mucci J, Risso MG, Leguizamón MS, Frasch AC, Campetella O. 2006. The trans-sialidase from Trypanosoma cruzi triggers apoptosis by target cell sialylation. Cell Microbiol. 8:1086-1095.
25. Nagamune K, Acosta-Serrano A, Uemura H, Brun R, Kunz-Renggli C, Maeda Y, Ferguson MA, Kinoshita T. 2004. Surface sialic acids taken from the host allow trypanosome survival in tsetse y vectors. J Exp Med. 199:1445-1450.
26. Nayak DP, Reichl U. 2004. Neuraminidase activity assays for monitoring MDCK cell culture derived inuenza virus. J Virol Methods. 122:9-15.
27. Neres J, Buschiazzo A, Alzari PM, Walsh L, Douglas KT. 2006. Continuous uorimetric assay for high-throughput screening of inhibitors of trans-sialidase from Trypanosoma cruzi. Anal Biochem. 357:302-304.
28. Neres J, Brewer ML, Ratier L, Botti H, Buschiazzo A, Edwards PN, Mortenson PN, Charlton MH, Alzari PM, Frasch AC, et al. 2009. Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening. Bioorg Med Chem Lett. 19:589-596.
29. Pereira-Chioccola VL, Acosta-Serrano A, Correia de Almeida I, Ferguson MA, Souto-Padron T, Rodrigues MM, Travassos LR, Schenkman S. 2000. Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alphagalactosyl antibodies. J Cell Sci. 113:1299-1307.
30. Piochon M, Legault J, Gauthier C, Pichette A. 2009. Synthesis and cytotoxicity evaluation of natural α-bisabolol β-D-fucopyranoside and analogues. Phytochemistry. 70:228-236.
31. Ratier L, Urrutia M, Paris G, Zarebski L, Frasch AC, Goldbaum FA. 2008. Relevance of the diversity among members of the Trypanosoma cruzi trans-sialidase family analyzed with camelids single-domain antibodies. PLoS One. 3:e3524.
32. Ribeirão M, Pereira-Chioccola VL, Eichinger D, Rodrigues MM, Schenkman S. 1997. Temperature differences for trans-glycosylation and hydrolysis reaction reveal an acceptor binding site in the catalytic mechanism of Trypanosoma cruzi trans-sialidase. Glycobiology. 7:1237-1246.
33. Risso MG, Pitcovsky TA, Caccuri RL, Campetella O, Leguizamón MS. 2007. Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections. Parasitology. 134:503-510.
34. Ross AJ, Ivanova IA, Ferguson MAJ, Nikolaev AV. 2001. Parasite glycoconjugates. Part 11. Preparation of phosphodisaccharide synthetic probes, substrate analogues for the elongating α-D-mannopyranosylphosphate transferase in the Leishmania. J Chem Soc Perkin Trans. 1:72-81.
35. Schenkman S, Jiang MS, Hart GW, Nussenzweig V. 1991. A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specic epitope required for invasion of mammalian cells. Cell. 65:1117-1125.
36. Schrader S, Tiralongo E, Paris G, Yoshino T, Schauer R. 2003. A nonradioactive 96-well plate assay for screening of trans-sialidase activity. Anal Biochem. 322:139-147.
37. Schrader S, Schauer R. 2007. Nonradioactive trans-sialidase screening assay. In: Brockhausen I, editor. Methods in Molecular Biology. Glycobiology Protocols. Vol. 347. Totowa, NJ: Humana Press, Inc. p. 93-107.
38. Tiralongo E, Schrader S, Lange H, Lemke H, Tiralongo J, Schauer R. 2003. Two trans-sialidase forms with different sialic acid transfer and sialidase activities from Trypanosoma congolense. J Biol Chem. 278:23301-23310.
39. Tomlinson S, Pontes de Carvalho LC, Vandekerckhove F, Nussenzweig V. 1994. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement. J Immunol. 153:3141-3147.
40. Veh RW, Michalski J, Corfield AP, Sander-Wewer M, Gies D, Schauer R. 1981. New chromatographic system for the rapid analysis and preparation of colostrum sialyloligosaccharides. J Chromatogr A. 212:313-322.
41. Williamson YM, Gowrisankar R, Longo DL, Facklam R, Gipson IK, Ades EP, Carlone GM, Sampson JS. 2008. Adherence of nontypeable Streptococcus pneumoniae to human conjunctival epithelial cells. Microb Pathogen. 44:175-185.